An Update on the Xenograft and Mouse Models Suitable for Investigating New Therapeutic Compounds for the Treatment of B-Cell Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|21|2023-2039

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.21, 2008-07, pp. : 2023-2039

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies

By Bornstein Gadi Quéva Christophe Tabrizi Mohammad Abbema Anne Chavez Carlos Wang Ping Foord Orit Ahluwalia Kiran Laing Naomi Raja Sandhya Wen Shenghua Green Larry Yang Xiaodong Webster Carl Stewart Ross Blakey David

Investigational New Drugs, Vol. 28, Iss. 5, 2010-10 ,pp. : 561-574

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic evaluation and therapeutic activity of bendamustine in B-cell lymphoid malignancies

By Korycka-Wołowiec Anna Robak Tadeusz

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1455-1468

Informa Healthcare

Access to resources Recommend Favorite

Idiotype Vaccines for Human B-Cell Malignancies

Current Pharmaceutical Design, Vol. 16, Iss. 3, 2010-01 ,pp. : 300-307

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Vaccination for the Immunotherapy of B-Cell Malignancies

Current Gene Therapy, Vol. 2, Iss. 2, 2002-01 ,pp. : 235-242

Bentham Science Publishers

Access to resources Recommend Favorite

New agents and approaches to the treatment of B-cell non-Hodgkin lymphoma

By Burton Jack D Goldenberg David M

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 4, 2010-12 ,pp. : 569-583

Informa Healthcare

Access to resources Recommend Favorite